Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apevitin BC vs Vitamin Complex for Appetite Stimulation
NCT01283646Phase 3Completed
- Sponsor
- EMS
- Start
- Oct 2011
- Primary completion
- May 2012
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Apevinat BC in Loss of appetite (2 arms), sponsored by EMS. Primary endpoint: Effectiveness of Apevitin BC in appetite stimulation at 30 days. Started Oct 2011; status: completed.
02
Drugs
Apevinat BC
03
Conditions
Loss of appetite
Beyond the preview
Go deeper on NCT01283646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283646.